Direktorat Registrasi ObatValid

CEFEPIME HCL MONOHYDRATE

Claim this product
BPOM Number
GKL1140300544A1
Approved
1 October 2025
Expiry
30 September 2030
Form
SERBUK INJEKSI

About This Registration

CEFEPIME HCL MONOHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1140300544A1. Its current registration status is Valid, with the licence valid until 30 September 2030. The product is registered to NATURA LABORATORIA PRIMA - INDONESIA. BPOM first approved this registration in September 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 1 VIAL @ 1 G
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

KOMBINASI-CEFEPIME HCL MONOHYDRATE BUFFERED WITH ARGININE

Market Intelligence

Owner Portfolio
NATURA LABORATORIA PRIMA - INDONESIA holds 91 BPOM registrations
Manufacturer Scale
NATURA LABORATORIA PRIMA - INDONESIA produces 91 registered products
Registration Age
Registered for 9 months

FDA Cross-Reference

via openFDA
Generic Name
CEFEPIME
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAMUSCULAR

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from NATURA LABORATORIA PRIMA - INDONESIA

MOXIFLOXACIN HYDROCHLORIDE

-GKL2540312749A1
Valid
Approved: Dec 6, 2025INFUS
View product →

PIRACETAM

-GKL1240302649A1
Valid
Approved: Nov 13, 2025INFUS
View product →

CEFEPIME HCL MONOHYDRATE

-GKL1140300544A1
Valid
Approved: Sep 30, 2025SERBUK INJEKSI
View product →

LEVOFLOXACIN HEMIHYDRATE

-GKL1640308949A1
Valid
Approved: Sep 25, 2025INFUS
View product →

GABAPENTIN

-GKL1740310001A1
Valid
Approved: Aug 31, 2025KAPSUL
View product →

Products in the same class

BENDAMUSTINE HCL MONOHYDRATE

-GKL2134615944A1
Valid
Approved: Nov 1, 2025SERBUK INJEKSI LIOFILISASI
FERRON PAR PHARMACEUTICALS
View product →

TRIAMCINOLONE

-GKL1015710210A1
Valid
Approved: Sep 29, 2025TABLET
ETERCON PHARMA - INDONESIA
View product →

LANSOPRAZOLE

-GKL0308508603A1
Valid
Approved: Sep 17, 2025KAPSUL LEPAS TUNDA
HEXPHARM JAYA LABORATORIES - INDONESIA
View product →

LODIXON 8

-DKL2031411110A1
Valid
Approved: Sep 12, 2025TABLET
LLOYD PHARMA INDONESIA - INDONESIA
View product →

COTRIMOXAZOLE

-GKL1002343333A1
Valid
Approved: Aug 20, 2025SUSPENSI
BERNOFARM - INDONESIA
View product →
1